Related Experiment Videos
Selective decrease in serum immunoglobulin G1. A tissue nonspecific tumor marker detecting early stages of
E Schauenstein1, M Lahousen, M Weblacher
1Department of Biochemistry, University of Graz, Graz, Austria.
Cancer
|August 1, 1996
Summary
The percentage of Immunoglobulin G1 (IgG1) in serum shows promise as a sensitive marker for detecting gynecologic cancers, particularly at early stages. This IgG subclass shift can aid in noninvasive diagnosis, often outperforming traditional tumor markers.
Area of Science:
- Gynecologic Oncology
- Immunology
- Biomarker Discovery
Background:
- Malignant diseases are associated with characteristic shifts in serum IgG subclass patterns.
- Specifically, a reduction in IgG1 and an increase in IgG2 relative to total IgG has been observed.
Purpose of the Study:
- To evaluate the diagnostic performance of IgG subclass shifts as an indirect tumor marker.
- To assess this marker in patients with carcinomas of the ovary, cervix, and corpus uteri.
Main Methods:
- Quantitative affinity chromatography was used to determine IgG1 and IgG2 percentages in 207 gynecologic cancer patients.
- Data were compared to 135 healthy females and 52 patients with benign gynecologic diseases.
Main Results:
- Cancer patients showed significantly different IgG1 and IgG2 percentages compared to controls and benign disease groups.
- IgG1 percentage demonstrated high specificity (90-100%) for discriminating cancer patients.
- IgG1 was more sensitive than conventional markers (CA 125, TPA, CEA, Ferritin, SCC) for cervical and corpus uteri cancers, especially in early stages.
Conclusions:
- Determination of IgG1 percentage offers valuable information for noninvasive detection of gynecologic cancers.
- Combining IgG1 with conventional markers like CA 125 and TPA enhances diagnostic sensitivity across all studied tumor sites.